About this item:

759 Views | 32 Downloads

Author Notes:

Correspondence: Vin Tangpricha, Division of Endocrinology, Diabetes and Lipids, WMRB 1301, 101 Woodruff Circle NE, Atlanta GA 30322, USA. Tel.: +1 404 727 7254; Fax: +1 404 727 1300; vin.tangpricha@emory.edu

The authors would like to acknowledge the assistance from the staff of the Emory University Cystic Fibrosis Center, Dr Arlene Stecenko and Dr Michael Schechter.

Subject:

Research Funding:

This work was supported by grants from Proctor & Gamble Pharmaceuticals, NIH Grant #K23AR054334 and Cystic Fibrosis Foundation Center Grant, #C029-07, University Research Committee (URC) of Emory University and the UV Foundation.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Endocrinology & Metabolism
  • D DEFICIENCY
  • 25-HYDROXYVITAMIN-D CONCENTRATIONS
  • VERTEBRAL FRACTURE
  • PULMONARY-DISEASE
  • OSTEOPOROSIS
  • WOMEN
  • RISK
  • MEN
  • ERGOCALCIFEROL
  • DENSITY

Vitamin D and bone health in adults with cystic fibrosis

Tools:

Journal Title:

Best Practice and Research: Clinical Endocrinology and Metabolism

Volume:

Volume 69, Number 3

Publisher:

, Pages 374-381

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Background: Cystic fibrosis (CF) patients have chronic pancreatic insufficiency leading to malabsorption of fat-soluble vitamins, including vitamin D which can contribute to poor skeletal health and respiratory function. Objective: This study evaluated the prevalence of vitamin D insufficiency and its impact on bone and respiratory health in adults with CF. Design and measurements: This was a retrospective study in which data were collected from medical records over a 2-year period. Data included patient demographics, lung function, biochemical data, bone mineral densities, X-rays and ascertainment of use of vitamin supplements. Data were collected from medical records at a single accredited CF Center. Serum 25-hydroxyvitamin D [25(OH)D] levels and bone mineral density studies were also collected. Patients: A total of 185 adults with CF were identified with a mean age of 29 ± 9 years. Results: The prevalence of vitamin D insufficiency [25(OH)D < 75 nmol/l] was 76%. Mean serum 25(OH)D concentrations were 58.8 ± 30 nmol/l. Use of specific vitamin D supplementation was protective against vitamin D insufficiency whereas use of multivitamins was not. There was a small, but significant, positive association between serum 25(OH)D and FEV1 per cent predicted after controlling for age, gender, BMI and race (R2 = 0.30, P < 0.001). A high prevalence (27%) of vertebral fractures was detected on lateral chest X-ray. Conclusions: The prevalence of vitamin D insufficiency and poor skeletal health is high in the US CF population. Vitamin D status appears to be positively associated with lung function. Prospective studies to examine the impact of correction of vitamin D insufficiency on skeletal and lung health in adult CF are warranted. © 2008 The Authors.

Copyright information:

© The Authors

Export to EndNote